Hydrolytic Degradation Study of Lansoprazole, Identification, Isolation and Characterisation of Base Degradation Product
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53396#.VMCLTCzQrzE
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53396#.VMCLTCzQrzE
ABSTRACT
Lansoprazole
degradation is accelerated in both acidic and basic medium in water.
The present investigation deals with the hydrolytic degradation of
Lansoprazole. Acidic medium degradation show all known impurities and
degradation products whereas basic degradation studies show new impurity
which has higher molecular weight than Lansoprazole. New impurity was
identified, isolated using mass based auto purification system and
characterised by 1H NMR, 13C NMR, HMBC, HSQC, NOE,
COSY and HRMS experiments. Isolated impurity was showing molecular
weight of 467.10, molecular formula of C23H16F3N5OS
and its name is 7-(3-Methyl-4-(2,2,2-trifluoroethoxy)
pyridin-2-yl)-7H-benzo[4,5]imidazo[2,1-b]benzo[4,5]imidazo[2,1-d][1,3,5]thiadiazine.
KEYWORDS
Lansoprazole, Hydrolytic Degradation, Isolation, Characterization, Preparative HPLC, 1H NMR, 13C NMR and 2 D NMR
Cite this paper
References
Battu,
S. and Pottabathini, V. (2015) Hydrolytic Degradation Study of
Lansoprazole, Identification, Isolation and Characterisation of Base
Degradation Product. American Journal of Analytical Chemistry, 6, 145-155. doi: 10.4236/ajac.2015.62013.
[1] | Richter,
J.E., Campbell, D.R., Kahrilas, P.J., Huang, B. and Fludas, C. (2000)
Lansoprazole Compared with Ranitidine for the Treatment of Nonerosive
Gastroesophageal Reflux Disease. Archives of Internal Medicine, 160,
1803-1809. http://dx.doi.org/10.1001/archinte.160.12.1803 |
[2] | Brummer, R.J., Geerling, B.J. and Stockbrugger, R.W. (1997) Initial and Chronic Gastric Acid Inhibition by Lansoprazole and Omeprazole in Relation to Meal Administration. Digestive Disease and Sciences, 42, 132-137. |
[3] | Tang, G., Serfaty-Lacronsniere, C., Camilo, M.E. and Russell, R.M. (1996) Gastric Acidity Influences the Blood Response to a Beta-Carotene Dose in Humans. American Journal of Clinicle Nutrition, 64, 22-26. |
[4] | Tolman,
K.G., Sanders, S.W., Buchi, K.N., Karol, M.D., Jennings, D.E. and
Ringham, G.L. (1997) The Effects of Oral Doses of Lansoprazole and
Omeprazole on Gastric pH. Journal of Clinicle Gastroenterology, 24,
65-70. http://dx.doi.org/10.1097/00004836-199703000-00003 |
[5] | Fitton,
A. and Wiseman, L. (1996) Pantoprazole: A Review of Its Pharmacological
Properties and Therapeutic Use in Acid-Related Disorders. Drugs, 51,
460-482. http://dx.doi.org/10.2165/00003495-199651030-00012 |
[6] | Matheson,
A.J. and Jarvis, B. (2001) Lansoprazole: An Update of Its Place in the
Management of Acid-Related Disorders. Drugs, 61, 1801-1833. http://dx.doi.org/10.2165/00003495-200161120-00011 |
[7] | Nudelman, N.S. and Estabilidad de (1975) Medicamentos. EI Ateno, Buenos Aires. |
[8] | Kommanaboyina,
B. and Rhodes, C.T. (1999) Trends in Stability Testing, with Emphasis
on Stability during Distribution and Storage. Drug Development and
Industrial Pharmacy, 25, 857-868. http://dx.doi.org/10.1081/DDC-100102246 |
[9] | Karljikovic-Rajic, K., Novovic, D., Marinkovic, V. and Agbaba, D. (2003) Journal of Pharmaceutical and Biomedical Analysis, 32, 1019-1027. |
[10] | Anil Kumar, A., Venkata Ramana, K., Narasimha Raju, C.H. and Sudhakara Rao, G. (2012) A Simple UV Spectrophotometric Method for Determination of Lansoprazole in Bulk and Pharmaceutical Dosage Forms. International Journal of Pharmaceutical, Chemical and Biological Sciences, 2, 524-528. |
[11] | Alagar raja, M., Yadav, S.K., Rai, A. and Mishra, S. (2011) Analytical Estimation of Lansoprazole and Validation of Simple Spectrophotometric in Bulk and Capsule Formulation. International Journal of Research in Pharmaceutical Sciences, 2, 521-524. |
[12] | Okram,
Z.D., Kanakapura, B., Jagannathamurthy, R.P. and Basavaiah, V.K. (2012)
Development of a Simple UV-Spectrophotometric Method for the
Determination of Lansoprazole and Study of Its Degradation Profile.
Química Nova, 35, 386-391. http://dx.doi.org/10.1590/S0100-40422012000200027 |
[13] | Rao,
P.V., Kumar, M.N. and Kumar, M.R. (2013) A Novel, Validated
Stability-Indicating UPLC Method for the Estimation of Lansoprazole and
Its Impurities in Bulk Drug & Pharmaceutical Dosage Forms. Scientia
Pharmaceutica, 81, 183-193. http://dx.doi.org/10.3797/scipharm.1210-09 |
[14] | Al-Momani,
I.F. and Rababah, M.H. (2010) Validation of HPLC and FIA
Spectrophotometric Methods for the Determination of Lansoprazole in
Pharmaceutical Dosage Forms and Human Plasma. American Journal of
Analytical Chemistry, 1, 34-39. http://dx.doi.org/10.4236/ajac.2010.11005 |
[15] | Muthu Kumar, S., Selva Kumar, D., Raj Kumar, T., Udhaya Kumar, E., Suba Geetha, A. and Diwedi, D. (2010) Development and Validation of RP-HPLC Method for the Estimation of Lansoprazole in Tablet Dosage Form. Journal of Chemical and Pharmaceutical Research, 2, 291-295. |
[16] | Luo, Y.F., Xu, L.S., Xu, M., Feng, J. and Tang, X. (2012) A Validated Specific, Stability Indicating HPLC Method for Determination of Lansoprazole Enteric Coated Capsules and Related Impurities. Asian Journal of Pharmaceutical Sciences, 7, 149-154. |
[17] | Patel, B., Dedani, Z., Dedani, R., Ramolia, C., Sagar, V. and Mehta, R.S. (2009) Simultaneous Estimation of Lansoprazole and Domperidone in Combined Dosage Form by RP-HPLC. Asian Journal of Research in Chemistry, 2, 210-212. |
[18] | Brown,
S.D., Connor, J.D., Smallwood, N.C. and Lugo, R.A. (2011)
Quantification of Lansoprazole in Oral Suspension by
Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap
Time-of-Flight Mass Spectrometry. International Journal of Analytical
Chemistry, 2011, Article ID: 832414. http://dx.doi.org/10.1155/2011/832414 |
[19] | Katsuki,
H., Hamada, A., Nakamura, C., Arimori, K. and Nakano, M. (2011)
High-Performance Liquid Chromatographic Assay for the Simultaneous
Determination of Lansoprazole Enantiomers and Metabolites in Human Liver
Microsomes. Journal of Chromatography B, 757, 127-133. http://dx.doi.org/10.1016/S0378-4347(01)00135-9 |
[20] | Cirilli,
R., Ferretti, R., Gallinella, B., Turchetto, L., Zanitti, L. and La
Torre, F. (2009) Development and Validation of an Enantioselective and
Chemoselective HPLC Method Using a Chiralpak IA Column to Simultaneously
Quantify(R)-(+)- and (S)-(?)-Lansoprazole Enantiomers and Related
Impurities. Journal of Pharmaceutical and Biomedical Analysis, 50, 9-14.
http://dx.doi.org/10.1016/j.jpba.2009.03.021 |
[21] | Petkovska,
R., Cornett, C. and Dimitrovska, A. (2008) Chemometrical Approach in
Lansoprazole and Its Related Compounds Analysis by Rapid Resolution
RP-HPLC Method. Journal of Liquid Chromatography & Related
Technologies, 31, 2159-2173. http://dx.doi.org/10.1080/10826070802225478 |
[22] | Srinivas, K.S.V., Mukkanti, K., Buchireddy, R. and Srinivasulu, P. (2010) Detection, Isolation and Characterisation of Principal Synthetic Route Indicative Impurity in Lansoprazole. E-Journal of Chemistry, 7, 844-848. |
[23] | Reddy,
G.M., Mukkanti, K., Laxmi Kumar, T., Moses Babu, J. and Reddy, P.P.
(2008) Synthesis and Characterization of Metabolites and Potential
Impurities of Lansoprazole, an Antiulcerative Drug. Synthetic
Communications, 38, 3477-3489. http://dx.doi.org/10.1080/00397910802162934 eww150122lx |
[24] | Ramulu, K., Rao, B.M. and Someswara Rao, N. (2013) Identification, Isolation and Characterization of Potential Degradation Product in Lansoprazole Drug Substance. Rasayan Journal of Chemistry, 6, 274-283. |
评论
发表评论